Krause Kevin Michael sold ANTX
January 2, 2024 · Form 4 insider transaction
Krause Kevin Michael sold 2,583 shares of AN2 Therapeutics, Inc. at $20.12 per share, a transaction worth $52.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,583
Price
$20.12
Total value
$52.0K
InsiderKrause Kevin Michael
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after1,914
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2023.; Price reported is a weighted-average sales price. The shares were sold at prices ranging from $20.00 to $20.26. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.